Navigation Links
Thomson CompuMark Reduces Drug Approval Delays by Identifying Conflicting Trademarks in International Markets

NORTH QUINCY, Mass., Jan. 24, 2012 /PRNewswire/ -- Thomson CompuMark, the global leader in trademark searching and brand protection solutions and part of Thomson Reuters, today announced the launch of Global Pharmaceutical Search, a new service providing targeted, global trademark intelligence in a single online report.

Avoiding potential confusion among pharmaceutical brands, which can sometimes lead to prescription errors, is a critically important public health concern. To address this, regulatory bodies in the United States and Europe have implemented rigorous processes for evaluating and approving pharmaceutical brand names. Searching globally for confusingly similar trademarks early in the process is important to minimize the chance of name rejection, which can be a costly misstep for pharmaceutical companies.

New Global Pharmaceutical Search addresses this critical need. It leverages Thomson CompuMark's industry-leading global trademark content—including common law and web content—to give brand owners comprehensive yet concise information on trademark availability from key pharmaceutical markets, all in a single report.

Search coverage includes Thomson CompuMark's proprietary, quality-checked trademark office records, web and domain name coverage, and U.S. and European regulatory and industry-specific sources, including pharmaceutical names in use. Brand owners can select the registers that match their product strategy, including the U.S., U.K., Spain, France, Germany, Switzerland, Italy, Benelux, and Canada.

Designed to save users valuable time, Global Pharmaceutical Search results are delivered online and also include access to the Analysis Tool on SERION®. This easy-to-use online analysis tool enables users to rapidly pinpoint potential conflicts, perform follow-up research on marks of interest with a single click, and create and share custom reports on their findings in seconds.

"In today's global pharmaceutical marketplace, brand owners need the most complete, global view of the trademark landscape to minimize business risk," said Anne Olson, vice president of Global Operations for Thomson CompuMark. "Our new Global Pharmaceutical Search provides that insight in a single, concise report that facilitates more informed decisions in less time. It's just another way we're using our global trademark expertise to help our customers launch the pharmaceuticals patients need – faster and more efficiently."

Olson noted that Thomson CompuMark also shares its global trademark expertise through industry-leading publications, including a recent Special Report on Pharmaceutical Trademark Trends. This report provides an overview of global pharmaceutical trademark trends, regulatory changes and clearance challenges, as well as best practices for selecting, researching and clearing new pharmaceutical brands. Visit the Thomson CompuMark website to request a copy of this Special Report.

Thomson Reuters
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals.  We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 55,000 people and operates in over 100 countries.  Thomson Reuters shares are listed on the Toronto and New York Stock Exchanges. For more information, go to


SOURCE Thomson Reuters
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BryanLGH Medical Center Implements Pharmacy Xpert from Thomson Reuters to Enhance Medication Management
2. Thomson Reuters-NPR Health Poll Finds Three in Four Americans Link Narcotic Pain Killers to Drug Addiction
3. Alabama Selects Thomson Reuters HIE Advantage™ for Statewide Health Information Exchange
4. Thomson Reuters - NPR Health Poll Finds Three-Quarters of Americans Support Government Insurance Subsidies for Birth Control Pills
5. Thomson Reuters Trademark Report Reveals New Challenges and Opportunities for Pharmaceutical Brands
6. Drug Combinations That May Cause Major Drug Interactions Common Among Seniors Who Take Antidepressants, According to Thomson Reuters Research
7. Higher Education Foundation in Brazil Seals Its Continued Relationship with Thomson Reuters for Academic Healthcare Content
8. Asia Pacific Pharma Companies Turning to High-Risk, High-Reward Drug Development, According to New Report from Thomson Reuters
9. Thomson Reuters Unveils Pharmacy Xpert Solution to Improve Medication Management for Hospital Pharmacists
10. Thomson Reuters Releases iPhone Support for Clinical Xpert Navigator
11. Federal Government Selects Thomson Reuters to Build Tool That Streamlines Comparative Effectiveness Research
Post Your Comments:
(Date:12/1/2015)... Calif. , Dec. 1, 2015 ... products and services, announced today that it has been ... services organization. Members served by Novation will have access ... devices, sports bracing products and soft goods dedicated to ... --> The aging U.S. population, rising prevalence ...
(Date:12/1/2015)... 2015 Russia has always been ... of new drugs registered in Europe in 2015 ... --> Russia has always been a country of ... registered in Europe in 2015 were tested in ... Russia has always been a country of choice for ...
(Date:12/1/2015)... CytRx Corporation (NASDAQ: CYTR ), a ... announced that it has reached its enrollment target of ... clinical trial of aldoxorubicin in patients with previously treated ... completed in Q1 2016. The Phase 3 trial is a ... Assessment from the FDA at 79 sites in ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... Growth in medical payments per workers’ compensation ... utilization of hospital and nonhospital care, according to a recent study by the Workers ... 16th Edition , found medical payments per claim with more than seven days of ...
(Date:12/1/2015)... ... December 01, 2015 , ... It’s official: Tattoo taboo is ... a number even greater among Millennials (a whopping one in three aged 18 to ... people who are dissatisfied with their ink. In fact, RealSelf , the world’s ...
(Date:12/1/2015)... ... 01, 2015 , ... For many X-rays taken at hospitals, ... interpretation by the radiologist. The marking utensils are so small, however, they are ... a way to alleviate this problem. , He developed the patent-pending MARK N ...
(Date:12/1/2015)... ... 01, 2015 , ... Next IT Healthcare, the leader in ... this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the publisher ... in the category of Digital Solutions for its innovative, industry-leading product, Alme Health ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Effective Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning ... results, once a deal is signed. This quick-read guidance suggests that failing ...
Breaking Medicine News(10 mins):